Skip to content

BC MEDICAL: what changed

BE 1015.395.802Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€41,297
2024 · -€2,262+€43,559
Equity
€41,201
2024 · €738+€40,464
Cash
€57,266
2024 · €1,137+€56,129
Balance sheet total
€63,614
2024 · €2,209+€61,405

Largest movements

2024 to 2025
Assets
  • Cash +€56,129

    up €56,129 (+4,935%), from €1,137 to €57,266

    mainly Net result for the year (+€41,297) and Other debts (+€20,245)

  • Deferred charges and accrued income +€2,280

    up €2,280 (+4,563%), from €50 to €2,330

  • Receivables within one year +€1,996

    up €1,996 (+195%), from €1,021 to €3,017

    of which Other amounts receivable: +€2,849

  • Tangible fixed assets +€1,000

    first reported in 2025, at €1,000

Equity and liabilities
  • Profit (loss) carried forward +€40,464

    up €40,464, from -€2,262 to €38,201

  • Other debts +€20,245

    up €20,245 (+2,003%), from €1,011 to €21,255

  • Trade debts +€697

    up €697 (+151%), from €460 to €1,157

Income statement
  • Gross operating margin +€54,656

    up €54,656, from -€2,240 to €52,416

  • Taxes +€10,951

    first reported in 2025, at €10,951

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€2,262
Gross operating margin +€54,656
Depreciation -€64
Financial charges -€81
Taxes -€10,951
Result 2025 €41,297
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€58,026
Investment -€1,064
Financing -€833
Cash 2024 €1,137
Net result for the year +€41,297
Depreciation +€64
Receivables within one year -€1,996
Deferred charges and accrued income -€2,280
Trade debts +€697
Other debts +€20,245
Investment in fixed assets (net) -€1,064
Contributions, distributions and other -€833
Cash 2025 €57,266
brings cash intakes cash out
Every line side by side 28 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,209 €63,614 +€61,405 +2,780%
Fixed assets 21/28 - €1,000 +€1,000
Tangible fixed assets 22/27 - €1,000 +€1,000
Furniture and vehicles 24 - €1,000 +€1,000
Current assets 29/58 €2,209 €62,614 +€60,405 +2,735%
Amounts receivable within one year 40/41 €1,021 €3,017 +€1,996 +195%
Trade receivables 40 €1,021 €169 -€852 -83.5%
Other amounts receivable 41 - €2,849 +€2,849
Cash at bank and in hand 54/58 €1,137 €57,266 +€56,129 +4,935%
Deferred charges and accrued income 490/1 €50 €2,330 +€2,280 +4,563%
Total equity and liabilities 10/49 €2,209 €63,614 +€61,405 +2,780%
Equity 10/15 €738 €41,201 +€40,464 +5,485%
Contributions 10/11 €3,000 €3,000 = 0.0%
Profit (loss) carried forward 14 -€2,262 €38,201 +€40,464
Amounts payable 17/49 €1,471 €22,412 +€20,942 +1,424%
Amounts payable within one year 42/48 €1,471 €22,412 +€20,942 +1,424%
Trade debts 44 €460 €1,157 +€697 +151%
Suppliers 440/4 €460 €1,157 +€697 +151%
Other amounts payable 47/48 €1,011 €21,255 +€20,245 +2,003%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 - €64 +€64
Gross operating margin 9900 -€2,240 €52,416 +€54,656
Operating profit (loss) 9901 -€2,240 €52,352 +€54,592
Financial charges 65/66B €23 €104 +€81 +361%
Recurring financial charges 65 €23 €104 +€81 +361%
Profit (loss) for the period before taxes 9903 -€2,262 €52,248 +€54,510
Income taxes 67/77 - €10,951 +€10,951
Profit (loss) for the period 9904 -€2,262 €41,297 +€43,559
Profit (loss) for the period to be appropriated 9905 -€2,262 €41,297 +€43,559

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€90,304 to €118,186

Midpoint €101,922 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €41,201
Capitalised earnings €139,407 to €195,170
Indication €90,304 to €118,186

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€41,201
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€41,201

Capitalised earnings

net result for the year (9904)
2025
€41,297
2024
-€2,262
Average result
€19,517
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€139,407 / €162,642 / €195,170

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.